应激性高血压犬鼠脑干及下丘脑-垂体-肾上腺轴中肾上腺髓质素及其受体mRNA表达的改变

采用逆转录- 聚合酶链式反应检测了慢性足底电击结合噪声应激致高血压大鼠下丘脑、延髓、中脑、垂体和肾上腺等组织中编码肾上腺髓质素的肾上腺髓质素前肽原(preproadrenomedullin, ppADM) 基因以及ADM 的特异性受体组件降钙素受体样受体(calcitonin-receptor-like receptor,CRLR)和受体活性调节蛋白2 和3(receptor-activity-modifying proteins, RAMP2 和RAMP3)表达的变化。我们观察到:与对照组相比,以 3- 磷酸甘油醛脱氢酶作为内参照,15 d 足底电击结合噪声应激引起下丘脑、垂体和肾上腺中ppADM mRNA表达上调,而在延髓和中脑表达明显下调(P<0.01 或 P<0.05); CRLR基因表达量正常时在下丘脑相对较高,应激15 d 后CRLR 表达在延髓、中脑和下丘脑下调(P<0.01 或 P<0.05), 而在垂体和肾上腺的表达无明显变化;应激后RAMP2 基因在延髓和下丘脑表达上调,而在肾上腺表达显著下调(P <0.01), 其他部位无明显变化;RAMP3 基因在对照组大鼠的中脑和下丘脑表达较高,在应激性高血压大鼠的下丘脑和垂体表达上调(P<0.01 或P<0.05), 而在中脑和肾上腺表达下调(P<0.05), 在延髓中的表达变化无统计学差异。上述结果提示:慢性足底电击结合噪声应激引起明显的中枢和下丘脑- 垂体-肾上腺轴ADM 及其受体组件CRLR/RAMP2 或CRLR/R     

慢性束缚应激大鼠海马脑啡肽mRNA和前强啡肽mRNA 表达及中药复方的影响

目的:研究慢性束缚应激时大鼠海马脑啡肽和前强啡肽mRNA基因表达的变化以及逍遥散、四君子汤、金匮肾气丸三种中药复方对其的影响.方法:用特制束缚架连续束缚7 d与21 d,每天3 h的方法制作大鼠束缚应激模型;以RT-PCR反应,扩增脑啡肽和前强啡肽基因,同时以β-actin作为内对照,用凝胶图像分析系统进行扫描并分析,把目的基因的光密度与内参照条带的光密度进行比较后进行半定量分析.结果:7 d模型组大鼠海马前强啡肽mRNA的表达明显增强(P＜0.01),21 d模型组海马脑啡呔mRNA和前强啡肽mRNA的表达明显增强(P＜0.01);三个复方均能降低海马内前强啡肽mRNA的表达(P＜0.01),逍遥散和四君子汤能降低脑啡呔mRNA的表达(P＜0.01).结论:逍遥散对脑啡呔mRNA前强啡肽mRNA的基因表达的改善作用明显优于金匮肾气丸组.     

应激性高血压大鼠脑干及下丘脑-垂体-肾上腺轴中肾上腺髓质素及其受体mRNA表达的改变

采用逆转录-聚合酶链式反应检测了慢性足底电击结合噪声应激致高血压大鼠下丘脑、延髓、中脑、垂体和肾上腺等组织中编码肾上腺髓质素的肾上腺髓质素前肽原(preproadrenomedullin,ppADM)基因以及ADM的特异性受体组件降钙素受体样受体(calcitonin-receptor-like receptor,CRLR)和受体活性调节蛋白2和3(receptor-activty-modifying proteins,RAMP2和RAMP3)表达的变化.我们观察到:与对照组相比,以3-磷酸甘油醛脱氢酶作为内参照,15 d足底电击结合噪声应激引起下丘脑、垂体和肾上腺中ppADM mRNA表达上调,而在延髓和中脑表达明显下调(P＜0.01或P＜0.05);CRLR基因表达量正常时在下丘脑相对较高,应激15 d后CRLR表达在延髓、中脑和下丘脑下调(P＜0.01或P＜0.05),而在垂体和肾上腺的表达无明显变化;应激后RAMP2基因在延髓和下丘脑表达上调,而在肾上腺表达显著下调(P＜0.01),其他部位无明显变化;RAMP3基因在对照组大鼠的中脑和下丘脑表达较高,在应激性高血压大鼠的下丘脑和垂体表达上调(P＜0.01或P＜0.05),而在中脑和肾上腺表达下调(P＜0.05),在延髓中的表达变化无统计学差异.上述结果提示:慢性足底电击结合噪声应激引起明显的中枢和下丘脑-垂体-肾上腺轴ADM及其受体组件CRLR/RAMP2或CRLR/RAMP3基因的表达变化.但慢性应激后中枢源性ADM及其受体的表达变化对应激和血压的调节以及在应激致高血压中的确切作用及机制尚待进一步研究.     

慢性束缚应激大鼠中枢糖皮质激素受体变化及中药复方的影响

目的:研究慢性束缚应激时大鼠脑内糖皮质激素受体的变化以及逍遥散、四君子汤、金匮肾气丸三种中药复方对其影响.方法:制作大鼠束缚应激模型,用特制束缚架连续束缚7 d与21 d,每天3 h用免疫组织化学方法结合图像分析检测中枢(海马CA1区、齿状回、大脑皮质)糖皮质激素受体的变化.结果:慢性束缚应激后,大鼠海马CA1区、大脑皮层和齿状回GR免疫反应阳性细胞平均总面积和阳性细胞数目在慢性应激的早期(7d模型组)明显增多(P＜0.05),免疫反应强度明显增强(P＜0.01).在慢性应激的后期(21 d模型组),则表现为相关脑区GR免疫反应阳性细胞平均总面积和阳性细胞数目均明显减少(P＜0.05),免疫反应强度明显减弱(P＜0.01).中药复方各组相关脑区神经元GR免疫反应阳性细胞平均总面积和阳性细胞数目较21 d模型组明显增高,免疫反应强度明显增强,三给药组之间并无明显差异,说明三给药组均能使GR含量保持于较高的状态,同时能保持GR免疫活性,其中又以逍遥散作用为明显.结论:逍遥散、四君子汤和金匮肾气丸明显逆转糖皮质激素受体下降趋势.     

慢性复合应激对大鼠学习和记忆及海马神经元神经颗粒素表达的影响

目的探讨慢性复合应激对大鼠学习和记忆功能及海马内神经元神经颗粒素(neurogranin,Ng)表达的影响。方法成年雄性Wistar大鼠随机分为对照组和复合应激组,复合应激组动物每天无规律交替暴露于复合应激原环境中,为期6周。应激结束后,用Morris水迷宫测试大鼠空间学习和记忆成绩,同时用免疫组织化学方法观察海马各亚区Ng表达的变化,并用RT-PCR技术分析各组大鼠海马Ng mRNA水平的变化。结果Morris水迷宫测试显示,应激组动物寻找隐蔽平台潜伏期明显短于对照组(P<0.05);应激组大鼠海马DG和CA3区Ng的蛋白表达水平明显高于对照组(P<0.05),而两组海马CA1区的Ng的免疫反应性无明显差别;与对照组相比,应激组动物的Ng mRNA水平亦明显上调(P<0.05)。结论慢性复合性应激大鼠的学习与记忆能力增强;Ng在海马中的表达和Ng mRNA转录水平增高,提示Ng参与了该增强机制。     

逍遥散对CUMS模型大鼠行为学及脑内单胺类神经递质的影响

目的:观察逍遥散对慢性温和不可预知应激(CUMS)模型大鼠的行为学及脑内单胺类神经递质含量的影响。方法:应用慢性温和不可预知应激程序对大鼠进行为期11周的造模,造模后3周,分别采用逍遥散(19.5g/kg、25.0g/kg)和丙咪嗪(15.0mg/kg)对模型大鼠进行为期8周的治疗。实验进程中,定期测定大鼠体重、糖水消耗量;应用开场实验测定大鼠爬行格子数和站立次数;造模、治疗结束后处死大鼠,解剖分离大鼠皮层和海马部位,采用荧光分光光度法测定5-HLAA、5-HT、DA和NE含量。结果:与正常对照组比较。大鼠造模后3周糖水消耗量、爬行格子数和站立次数均明显减少(P<0.01);与模型对照组比较,逍遥散19.5、25.0g/kg连续给药2周能显著增加糖水消耗量,但给药4周、7周对糖水消耗量影响不明显;与模型对照组比较,逍遥散25.0g/kg连续给药7周,对大鼠体重、爬行格子数和站立次数表现出提高趋势(P>0.05),逍遥散25.0g/kg连续给药8周,能明显提高模型大鼠皮层部位5-HT含量及海马部位5-HIAA含量(P<0.05,P<0.01)。结论:逍遥散对CUMS抑郁模型大鼠表现出抗抑郁作用,作用机制与影响脑内单胺类神经递质5-HT活性有关。     

重复制动应激对雌性大鼠下丘脑-垂体-卵巢轴的影响

目的: 探索重复制动应激对雌性大鼠下丘脑-垂体-卵巢轴的影响。方法: 40只SD雌鼠随机分为两组(n=20),对照组和实验组,一组正常饲养,一组采取递增负荷束缚应激,每天置于束缚器内制动应激一次(从上午9:00开始),第1日制动2 h,以后采用递增负荷,每日增加0.5 h,持续两周,通过检测体重、脏器系数、动情周期、性激素、病理和相关基因的表达探索其对下丘脑-垂体-卵巢轴的危害。结果: 重复制动应激使雌性大鼠体重下降、动情周期延长,卵巢和子宫的脏器系数和形态发生改变,利用qPCR技术对其相关基因检测,发现下丘脑促性腺激素释放激素、垂体促性腺激素释放激素受体、促卵泡生成素和促黄体生成素mRNA的表达显著下降,卵巢促卵泡生成素和黄体生成素受体 mRNA的表达显著上升,卵巢和子宫雌激素受体mRNA的表达显著下降。结论: 重复制动应激可能通过干扰下丘脑-垂体-卵巢轴的内分泌调节作用,使动情周期紊乱,从而损伤雌性动物的性腺和生殖内分泌功能。     

甘丙肽及其受体2在抑郁症动物模型脑内的表达研究

运用慢性非预见性应激刺激建立抑郁症动物模型,用开野实验（open—field）检测大鼠建模前后行为学变化,HPLC—EC法测定血清皮质醇变化,由此对模型进行初步评价。运用原位杂交、RT—PCR方法检测大鼠海马脑区和中缝背核甘丙肽及其受体2的表达。结果显示．慢性应激后模型组大鼠活动性明显降低,血清皮质醇含量显著升高,海马脑区和中缝背核甘丙肽及其受体2的表达显著上调。在慢性应激大鼠抑郁症模型中,甘丙肽及其受体2在部分脑区的高表达提示甘丙肽很有可能参与了应激过程中神经元功能的调节。     

大鼠发情期和间情期下丘脑ghrelin mRNA的表达

为探索下丘脑ghrelin mRNA及GnRH mRNA在大鼠(Rattus norregicus)发情期和间情期的表达特点,通过外部观察和阴道涂片相结合的方法确定发情期和间情期,将12只未经产SD雌性大鼠分为2组,即发情期组和间情期组,每组6只。取动物下丘脑,用实时荧光RT-PCR方法检测ghrelin mRNA和GnRH mRNA的表达丰度。结果表明,间情期组大鼠下丘脑ghrelin mRNA的表达丰度显著高于发情期组(P<0.01);间情期组大鼠下丘脑GnRH mRNA的表达丰度显著低于发情期组(P<0.01)。研究发现,下丘脑ghrelin mRNA和GnRH mRNA在发情期与间情期具不同的表达模式,提示ghrelin可能在下丘脑水平上对GnRH mRNA的表达具下调作用。     

Diurnal variation of corticotropin-releasing factor binding sites in the rat brain and pituitary

Summary 1. Corticotropin-releasing factor (CRF) is thought to be involved in the regulation of the diurnal activity of the hypothalamus-pituitary-adrenal (HPA) axis and to act as a neurotransmitter in the brain. To date it is unknown whether the binding sites of the central CRF system are subject to diurnal variations. 2. We measured the number of CRF binding sites over the course of a complete 24-hr light-dark cycle in the pituitary, amygdala, bed nucleus of the stria terminalis (BNST), cingulate cortex, visceral cortex, paraventricular nucleus of the hypothalamus, hippocampus, and locus ceruleus of rats byin vitro receptor autoradiography with iodinated ovine CRF. A 24-hr time course was also established for plasma CRF and corticosterone. 3. The diurnal pattern of plasma CRF does not correlate with the pattern of plasma corticosterone. Within the brain, CRF binding in the basolateral nucleus of the amygdala showed a U-shaped curve with maximum levels in the morning and a wide hallow between 1500 and 0100. A biphasic profile with a small depression in the afternoon and a more pronounced depression in the second half of the activity period is characteristic for the other brain areas and the pituitary. The profile for the pituitary correlates with those for the BNST and the area of the locus ceruleus. Furthermore, the diurnal pattern of CRF binding sites in the BNST correlates with that of the hippocampus, and the daytime pattern of the visceral cortex is similar to that of both the hippocampus and the BNST. 4. Since the CRF-binding profiles in the brain and the pituitary clearly differ from the profiles of both plasma CRF and corticosterone, one may assume that the diurnal pattern of central CRF binding sites is not directly coupled to the activity of the HPA axis.     

脾虚大鼠脑内IL-1β、IL-2 表达的变化及益气扶正中药的干预研究*

目的:研究脾虚模型大鼠脑内白细胞介素1 β(IL-1β)、白细胞介素2(IL-2)的活性表达,以及扶正益气中药的干预作用.方法:40只大鼠随机分成4组,正常组、模型组、治疗1组(四君子汤组)、治疗2组(玉屏风散组),每组各10只.采用苦降泻下、饮食失节加劳倦过度法建立大鼠脾虚模型,采用免疫组化法检测下丘脑腹侧核、海马CA1区的IL-1β和IL-2表达变化与四君子汤玉屏风散的治疗作用.结果:IL-1β在海马CA1区和下丘脑腹侧核表达明显降低,IL-2在海马CA1区和下丘脑腹侧核表达明显降低;四君子汤治疗组IL-1β和IL-2在上述脑区表达明显上升;玉屏风散治疗组IL-1β和IL-2在上述脑区表达呈紊乱变化现象.结论:益气扶正中药四君子汤、玉屏风散可能通过影响免疫器官、调控细胞因子IL-1β和IL-2活性表达而调节机体免疫功能.     

Inhibition of CRF- and urotensin I-stimulated ACTH release from goldfish pituitary cell columns by the CRF analogue alpha-helical CRF-(9-41)

alpha-Helical CRF-(9-41) is an analogue of corticotropin-releasing factor (CRF) that antagonizes CRF-stimulated ACTH release in rats. In the present study, alpha-helical CRF-(9-41) was tested to determine whether it would antagonize the ACTH-releasing activity of CRF or urotensin I (UI) observed with superfused, dispersed goldfish anterior pituitary cells. At a concentration of 4 microM, alpha-helical CRF-(9-41) completely blocked the ACTH-releasing activity of 100 nM CRF or 100 nM UI. The inhibitor by itself showed little intrinsic ACTH-releasing activity. This investigation reveals similarities in the CRF-antagonism of alpha-helical CRF-(9-41) in the teleost and mammalian pituitary in vitro. It also provides are similar and suggests that alpha-helical CRF-(9-41) may be useful as a tool to investigate the effects of CRF-like and UI-like peptides in teleost fishes.     

SOCS-3基因在Balb/c小鼠脑组织中的表达与脑不对称性

为探讨细胞因子信号传导抑制因子-3（suppresso of cytokine signaling-3, SOCS-3）在Balb/c小鼠皮层、海马、下丘脑中的表达及其与脑不对称性的关系.通过伸爪取食法将Balb/c小鼠分为左利组和右利组,取左、右侧皮层,左、右侧海马及下丘脑,以RT-PCR法间接测定SOCS-3 mRNA水平.结果表明：a.在左利鼠右侧皮层中,SOCS-3基因表达水平显著高于左侧皮层(P＜0.05);右利鼠左侧皮层SOCS-3表达显著高于左利鼠左侧皮层(P＜0.05).b.海马中SOCS-3表达：左利鼠右侧海马SOCS-3表达显著高于左侧海马(P＜0.05);右利鼠左侧海马SOCS-3表达显著高于左利鼠左侧海马(P＜0.05).c.右利鼠下丘脑中SOCS-3显著高于左利鼠(P＜0.05).上述研究结果提示,Balb/c小鼠脑中SOCS-3表达与脑不对称性有关.     

Neuropeptide Y administration acutely increases hypothalamic corticotropin-releasing factor immunoreactivity: lack of effect in other rat brain regions

The effect of acute central administration of Neuropeptide Y (NPY) to adult male rats on the brain content of corticotropin-releasing factor immunoreactivity (CRF-ir) was investigated. The brain regions studied included frontal cortex, hippocampus, medulla-pons, midbrain-thalamus, cerebellum, neurointermediate lobe of pituitary, median eminence and the remaining hypothalamus. CRF-ir was determined in each of these regions using a radioimmunoassay specific for rat CRF. CRF-ir was found to be significantly increased in the major site of CRF localization in the brain, the hypothalamus, in NPY-treated rats as compared to vehicle-treated controls either 15 minutes (p less than 0.025) or 45 minutes (p less than 0.005) post-injection. This increase was localized to the median eminence (p less than 0.05 after 15 minutes, p less than 0.01 after 45 minutes). No statistically significant differences were noted in any of the other brain regions assessed. Plasma adrenocorticotropin levels were also found to increase following NPY treatment, an effect which became significant after 45 minutes (p less than 0.05). These data show that NPY can alter the content of hypothalamic CRF and may play a role in its regulation.     

Brain and pituitary receptors for corticotropin releasing factor: Localization and differential regulation after adrenalectomy

Specific receptors for corticotropin releasing factor (CRF) were identified in two functionally distinct systems within the brain, the cortex and the limbic system. Autoradiographic mapping of the CRF receptors in the brain revealed high binding density throughout the neocortex and cerebellar cortex, subiculum, lateral septum, olfactory tract, bed nucleus of the stria terminalis, interpeduncular nucleus and superior colliculus. Moderate to low binding was found in the hippocampus, nucleus accumbens, claustrum, nucleus periventricularis thalamus, mammillary bodies, subthalamic nucleus, periaqueductal grey, locus coeruleus and nucleus of the spinal trigeminal tract. As in the anterior pituitary gland, CRF receptors in the brain were shown to be coupled to adenylate cyclase. However, in contrast to the marked decrease in CRF receptors observed after adrenalectomy in the anterior pituitary gland, CRF receptor concentration in the brain and pars intermedia of the pituitary was unchanged. The presence of CRF receptors in areas involved in the control of hypothalamic and autonomic nervous system functions is consistent with the major role of CRF in the integrated response to stress.     

Characteristics of glucocorticoid receptor gene expression in spontaneously hypertensive rat strain

In ISIAH rat strain with stress-sensitive form of hypertension, the expression level of glucocorticoid receptor (GR) gene has been evaluated in hippocampus, hypothalamus and pituitary under basal and 2-hr restraint stress conditions. Corticosterone (CS) level in peripheral blood was also evaluated. Normotensive WAG strain was used as a control. Under basal condition, there were no interstrain differences in GR-mRNA level in any brain region under study. However, under stress condition, ISIAH rats demonstrated a significant fall of GR-mRNA in hippocampus and increase the pituitary gland as compared to basal level. On the contrary, no differences with basal level were found in stressed WAG rats. CS concentration in blood was nearly the same in nonstressed WAG and ISIAH rats. Stress influence led to a marked increase of CS in both strains. However CS level was significantly higher in stressed ISIAH rats than in stressed WAG group.